1. Home
  2. IVVD vs PFL Comparison

IVVD vs PFL Comparison

Compare IVVD & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • PFL
  • Stock Information
  • Founded
  • IVVD 2020
  • PFL 2003
  • Country
  • IVVD United States
  • PFL United States
  • Employees
  • IVVD N/A
  • PFL N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • PFL Finance Companies
  • Sector
  • IVVD Health Care
  • PFL Finance
  • Exchange
  • IVVD Nasdaq
  • PFL Nasdaq
  • Market Cap
  • IVVD 351.6M
  • PFL 374.5M
  • IPO Year
  • IVVD 2021
  • PFL N/A
  • Fundamental
  • Price
  • IVVD $1.75
  • PFL $8.45
  • Analyst Decision
  • IVVD Strong Buy
  • PFL
  • Analyst Count
  • IVVD 5
  • PFL 0
  • Target Price
  • IVVD $5.11
  • PFL N/A
  • AVG Volume (30 Days)
  • IVVD 5.6M
  • PFL 113.7K
  • Earning Date
  • IVVD 11-13-2025
  • PFL 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • PFL 11.53%
  • EPS Growth
  • IVVD N/A
  • PFL N/A
  • EPS
  • IVVD N/A
  • PFL N/A
  • Revenue
  • IVVD $46,210,000.00
  • PFL N/A
  • Revenue This Year
  • IVVD $112.35
  • PFL N/A
  • Revenue Next Year
  • IVVD $272.14
  • PFL N/A
  • P/E Ratio
  • IVVD N/A
  • PFL N/A
  • Revenue Growth
  • IVVD 1941.08
  • PFL N/A
  • 52 Week Low
  • IVVD $0.35
  • PFL $6.98
  • 52 Week High
  • IVVD $2.74
  • PFL $8.62
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 64.77
  • PFL 42.31
  • Support Level
  • IVVD $1.56
  • PFL $8.56
  • Resistance Level
  • IVVD $2.01
  • PFL $8.65
  • Average True Range (ATR)
  • IVVD 0.19
  • PFL 0.07
  • MACD
  • IVVD 0.03
  • PFL -0.01
  • Stochastic Oscillator
  • IVVD 72.92
  • PFL 13.88

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

Share on Social Networks: